Mile-High Business: HempMeds to Sponsor Cannabis Business Summit in Denver
June 23 2014 - 9:00AM
HempMeds™ proudly announces its participation in and sponsorship of
the Cannabis Business Summit hosted by the National Cannabis
Industry Association in Denver. The conference takes place on June
24-25 at the Convention Center. The NCIA's mission is protecting
legitimate cannabis businesses, banking access for those
businesses, and fair tax policy. There will be a wide variety of
presentations from industry leaders; HempMeds is sponsoring a
networking session on June 24.
"A major challenge that cannabis-based businesses face is being
treated like any other business would," states Andrew Hard,
Director of Public Relations for HempMeds™. "We support the efforts
of the NCIA and feel that as the industry evolves, fair taxation
and banking regulations must be addressed. There will be an
estimated 800 business owners and professionals attending the
Cannabis Business Summit. That is a very good indication that the
stigma once surrounding cannabis-based businesses is being
eliminated, new businesses are sprouting up, and industry growth
will dictate the full acceptance of cannabis-based businesses in
the U.S."
NCIA member businesses receive two discounted admission tickets.
Non-members who wish to attend can register online. Admission can
be purchased at www.cannabisbusinesssummit.com.
"HempMeds™ is proud to be a leading hemp-based business featured
at the Cannabis Business Summit," Hard continues. "At the
conference we will address the Company's opinion that CBD-only
legislation is not prudent, as it does not allow access to the
'whole plant.' However, for states that have not or will not
legalize cannabis, CBD-rich hemp oil products are a readily
available option to try. The Company feels that trying CBD-rich
hemp oil products first should be a major consideration for
individuals and families prior to relocating to a legalized state.
HempMeds appreciates the NCIA for creating a platform for these
types of policy discussions to take place."
Members of the media wishing to attend and cover the conference
should contact Andrew Hard, Director of Public Relations at
HempMeds, for media passes. If by phone, call 917.660.5418 or email
to Andrew.Hard@hempmeds.com.
For more information on CBD-rich hemp oil products, please
visit:
HempMeds™ http://www.HempMeds.com 866.273.8502
Real Scientific Hemp Oil™ http://RealScientificHempOil.com
866.273.8502
Cibdex™ http://www.cibdex.com 866.273.8502
Cibaderm™ http://www.cibaderm.com 866.273.8502
The Company invites the public to get involved in the
conversation about CBD-rich hemp oil as it relates to HempMeds™
through the Company's social media websites on Facebook and
Twitter.
About HempMeds
HempMeds™ offers mainstream marketing, sales, customer
service, and logistics for the cannabis
industry. HempMeds™ is a corporate portfolio company
of Medical Marijuana, Inc. (OTC Pink:MJNA) and the
Company's exclusive master distributor and contracted
marketing company. In addition to handling sales and
distribution, HempMeds™ is the communication hub for the
Medical Marijuana Inc. portfolio of companies.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not
intended to diagnose, treat or cure any disease.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking
statements and information, as defined within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and is subject to the Safe Harbor
created by those sections. This material contains statements about
expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties.
Such forward-looking statements by definition involve risks,
uncertainties and other factors, which may cause the actual
results, performance or achievements of Medical Marijuana Inc. to
be materially different from the statements made herein.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products
that are in violation of the United States Controlled Substances
Act (US.CSA). The company does grow, sell and distribute hemp-based
products and are involved with the federally legal distribution of
medical marijuana-based products within certain international
markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT: For further information, please contact:
Andrew Hard
Director of PR, HempMeds
P. 858-380-5478
andrew.hard@hempmeds.com
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Apr 2023 to Apr 2024